Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells.
Toxicol Appl Pharmacol
; 287(1): 17-25, 2015 Aug 15.
Article
in En
| MEDLINE
| ID: mdl-25981168
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Carcinoma, Non-Small-Cell Lung
/
Vacuolar Proton-Translocating ATPases
/
ErbB Receptors
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
Toxicol Appl Pharmacol
Year:
2015
Type:
Article